Perbedaan Organon Pharma Indonesia Tbk. dan Sreeya Sewu Indonesia Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Sreeya Sewu Indonesia Tbk. diperdagangkan di Rp915 (kapitalisasi pasar 1,68 T, volume 24 jam 94,7 rb). Perbedaan utamanya: Sreeya Sewu Indonesia Tbk. jauh lebih besar — sekitar 16,1× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | SIPD | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 1,68 T |
Volume | — | 94,7 rb |
Lot | — | 947 |
Perputaran | — | 85,64 jt |
Harga Rata-rata | — | 904,37 |
Nilai Transaksi | — | 85,64 jt |
Harga Ekuilibrium Indikatif | — | 915 |
Volume Ekuilibrium Indikatif | — | 3 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →PT Sierad Produce Tbk (the Company) was established based on notarial deed No. 17 dated September 6, 1985 of Raden Santoso , notary in Jakarta and has been amenden based on the deed No. 27 dated April 16, 1986. PT. Sierad Produce is a chicken slaughterhouse and meat processing company founded in 1985. With four subsidiaries operating in the same line of business.
Selengkapnya di halaman SIPD →